There is an ongoing debate on whether chemotherapy is linked to dementia or not. Conflicting studies present differing ...

In this interview, Sir Prof. Cato T. Laurencin, the 2025 Coulter Lecturer, discusses how he is addressing today’s medical challenges using the technology of the future.

No refractures were reported during long-term follow-up at five yearsAt 24-months post-implantation, 89% of patients achieved bone unionNovadip plans market launch of NVD003 in 2027Mont Saint-Guibert, ...

Capricor Therapeutics saw its shares fall 13% by the end of trading Monday as its investigational cell therapy deramiocel for ...

Four physicians spoke on the panel, which was held at the Basketball Hall of Fame in Springfield, to discuss advancements in ...

It’s very important for diabetes to be diagnosed as soon as possible as it will get progressively worse if left untreated' ...

Some say our healthcare system needs to make a U-turn, a radical shift in its approach. Are we curing hypertension with our medications? Our approach to many musculoskeletal problems consists of ...

Biogen’s Skyclarys (omaveloxolone) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the ...

Imagine a creature so magical it seems ripped from the pages of a fantasy novel—a being that never truly ages, can regrow ...

Surviving a global disaster would take more than luck. It will require serious adaptability, resilience, and a little ...